In this episode: Why patients who stop GLP-1 therapy often return The first weeks of Medicare's obesity medication coverage The future of oral GLP-1 medications New implant technology from Novo Nordisk Muscle-preserving obesity treatments Why patient experience is becoming the next frontier in obesity medicine The goal of On The Pen has always been simple: translate complex obesity and diabetes news into information that helps you have better conversations with your doctor
The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia
Real patient taking CONTRAVE at the time of her interview and compensated for sharing her inspiring story
PubMed Wei, W., Zhao, H., Wang, A., Sui, M., Liang, K., Deng, H., Ma, Y., Zhang, Y., Zhang, H., and Guan, Y
The prebiotic clears out bad bacteria to make room for the good stuff